An improved mouse model of sepsis based on intraperitoneal injections of the enriched culture of cecum slurry.

Antibiotics Cecal slurry (CS) Intraperitoneal Polymicrobial Sepsis

Journal

Life sciences
ISSN: 1879-0631
Titre abrégé: Life Sci
Pays: Netherlands
ID NLM: 0375521

Informations de publication

Date de publication:
23 Mar 2024
Historique:
received: 08 12 2023
revised: 07 02 2024
accepted: 18 03 2024
medline: 26 3 2024
pubmed: 26 3 2024
entrez: 25 3 2024
Statut: aheadofprint

Résumé

Sepsis is a life-threatening clinical syndrome comprising multiorgan dysfunctions caused by a disproportionate body immune response. There are several animal sepsis models which are based on cecum ligation, cecal puncture, and cecum slurry injection. The major limitation of all current sepsis models is the high variability owing to the variable degree of ligation, puncture and inconsistent microbial composition used for sepsis initiation. The primary objective of this work is to demonstrate the feasibility of a standardized method for sepsis development. The cecal slurry bacterial culture was developed and preserved in glycerol stocks. Antibiotics aztreonam and vancomycin were used for generating several defined, enriched cecal slurry bacterial cultures. Mice survival was assessed until 48 h post injection, and the tissue samples were collected after 10 h from sepsis initiation. The results indicate that increasing polymicrobial load resulted in lower survival rates and was associated with the higher number of infiltrating immune cells and necrosis. H&E (haematoxylin & eosin) staining & serum markers revealed that septic mice exhibited increased inflammation and significant damage to the liver and kidneys. The defined Gram-negative and Gram-positive specific cecal slurry bacterial cultures were developed and their efficiency in inducing sepsis was characterized. Enriched cecal slurry bacterial cultures can be stored in glycerol stocks at -80 °C. This has an ethical advantage of avoiding unnecessary animal euthanasia for each experiment and provides a standardization capability of sepsis development.

Identifiants

pubmed: 38527668
pii: S0024-3205(24)00173-5
doi: 10.1016/j.lfs.2024.122584
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

122584

Informations de copyright

Copyright © 2024. Published by Elsevier Inc.

Déclaration de conflit d'intérêts

Declaration of competing interest No competing interests declared.

Auteurs

Rajat Atre (R)

Department of Biosciences and Biomedical Engineering (BSBE), Indian Institute of Technology Indore (IITI), Indore, India.

Rahul Sharma (R)

Department of Biosciences and Biomedical Engineering (BSBE), Indian Institute of Technology Indore (IITI), Indore, India.

Alexander G Obukhov (AG)

Department of Anatomy, Cell Biology & Physiology, Indiana University School of Medicine, Indianapolis, IN 46202, USA; Stark Neurosciences Research Institute, Indiana University School of Medicine, Indianapolis, IN 46202, USA.

Uzma Saqib (U)

School of Life Sciences, Devi Ahilya Vishwavidyalaya, Vigyan Bhawan, Khandwa Road Campus, Indore 452 001, MP, India.

Sadiq Umar (S)

Department of Oral Biology, College of Dentistry, The University of Illinois at Chicago, Chicago, USA.

Gajanan N Darwhekar (GN)

Acropolis Institute of Pharmaceutical Education and Research (AIPER), Indore, India.

Mirza S Baig (MS)

Department of Biosciences and Biomedical Engineering (BSBE), Indian Institute of Technology Indore (IITI), Indore, India. Electronic address: msb.iit@iiti.ac.in.

Classifications MeSH